MHRA recalls Ventolin Syrup containing glass fragments
Practice The MHRA has recalled two batches of the asthma medicine Ventolin Syrup over fears they could contain fragments of glass.
The MHRA has recalled two batches of the asthma medicine Ventolin Syrup over fears they could contain fragments of glass.
The medicines watchdog issued a drug alert yesterday (June 12) for the recall of batches M005 and M006 of the sugar-free syrup 2mg in 5ml. The prescription-only medicine is used to treat asthma in adults and children and is supplied by Glaxo Wellcome Ltd, trading as Allen & Hanburys.
E-cigarettes to be licensed as medicines by 2016The MHRA said 1,375 bottles of the affected batches have been distributed to pharmacies and there is less than a one-in-1,000 chance of a bottle having a defect.
There have been no adverse reactions reported to the company, but patients who have been prescribed the syrup should check the batch numbers, the MHRA said.
MHRA head of defective medicines report centre Adam Burgess said patients should contact their doctor if they have taken medicines from any of the affected batches and contact their pharmacy which will give them a replacement.
